INFI - Infinity Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue18,723109,066164,995
Cost of Revenue---
Gross Profit18,723109,066164,995
Operating Expenses
Research Development119,611199,109143,633
Selling General and Administrative-69,99737,06529,285
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-30,891-127,108-7,923
Income from Continuing Operations
Total Other Income/Expenses Net2,015435339
Earnings Before Interest and Taxes-28,876-126,673-7,584
Interest Expense1,2251,3689,649
Income Before Tax-30,101-128,041-17,233
Income Tax Expense-335183
Minority Interest---
Net Income From Continuing Ops-30,101-128,376-17,416
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-30,101-128,376-17,416
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-30,101-128,376-17,416